Lilly Eli Co stock is traded at $1,430.30, with a volume of 957,901. It is down -0.14% in the last 24 hours and up +21.29% over the past month. Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Previous Close:
$1,432.29
Open:
$1,418.08
24h Volume:
957,901
Relative Volume:
0.25
Market Cap:
$1.27T
Revenue:
$72.25B
Net Income/Loss:
$25.28B
P/E Ratio:
51.48
EPS:
$27.78
Net Cash Flow:
$10.37B
1W Performance:
+0.87%
1M Performance:
+21.29%
6M Performance:
+47.91%
1Y Performance:
+44.68%
1-Day Range:
$1,414.37$1,433.71
1-Week Range:
$1,333.22$1,453.00
52-Week Range:
$850.51$1,453.00
Lilly Eli Co Stock (LLY) Company Profile
Name
Lilly Eli CoSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(317) 276-2000Address
LILLY CORPORATE CTR, INDIANAPOLIS, IN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS